Citigroup Inc Amphastar Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 57,812 shares of AMPH stock, worth $2.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,812

Previous 34,995 65.2%

Holding current value

$2.58 Million

Previous $1.4 Million 100.5%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$36.99 - $50.09 $844,000 - $1.14 Million	22,817 Added 65.2%	57,812 $2.81 Million
Q2 2024 Aug 12, 2024	BUY	$38.65 - $43.48 $1,816 - $2,043	47 Added 0.13%	34,995 $1.4 Million
Q1 2024 May 10, 2024	BUY	$42.85 - $63.45 $171,742 - $254,307	4,008 Added 12.95%	34,948 $1.53 Million
Q4 2023 Feb 09, 2024	SELL	$44.49 - $62.93 $473,818 - $670,204	-10,650 Reduced 25.61%	30,940 $1.91 Million
Q3 2023 Nov 09, 2023	BUY	$45.51 - $65.0 $174,803 - $249,665	3,841 Added 10.18%	41,590 $1.91 Million
Q2 2023 Aug 10, 2023	BUY	$35.77 - $58.38 $465,010 - $758,940	13,000 Added 52.53%	37,749 $2.17 Million
Q1 2023 May 11, 2023	SELL	$27.99 - $37.92 $195,874 - $265,364	-6,998 Reduced 22.04%	24,749 $928,000
Q4 2022 Feb 09, 2023	BUY	$27.93 - $31.27 $21,143 - $23,671	757 Added 2.44%	31,747 $889,000
Q3 2022 Nov 10, 2022	SELL	$27.56 - $37.75 $9,618 - $13,174	-349 Reduced 1.11%	30,990 $871,000
Q2 2022 Aug 10, 2022	SELL	$29.79 - $42.29 $218,211 - $309,774	-7,325 Reduced 18.95%	31,339 $1.09 Million
Q1 2022 May 12, 2022	BUY	$22.96 - $36.45 $188,823 - $299,764	8,224 Added 27.02%	38,664 $1.39 Million
Q4 2021 Feb 10, 2022	SELL	$18.14 - $23.29 $1,251 - $1,607	-69 Reduced 0.23%	30,440 $709,000
Q3 2021 Nov 10, 2021	BUY	$17.83 - $21.49 $543,975 - $655,638	30,509 New	30,509 $580,000

Others Institutions Holding AMPH

# of Institutions

286

Shares Held

35.1M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.19B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account